The BEVATOMOX phase II trial: raltitrexed/oxaliplatin/bevacizumab vs mFOLFOX6/bevacizumab in 2nd-line metastatic colorectal cancer

Authors

Thomas Simon (ORCID: https://orcid.org/0000-0001-9699-959X)
Stéphane Jacquot
Catherine Fiess
F. Khemissa Akouz
T. Mazard
Stephen G. Ellis (ORCID: https://orcid.org/0000-0001-6239-9772)
E. Samalin
E. Assenat
Marc Ychou
Mohamed Ramdani
Fabienne Portales
Laurent Mineur

Institutions

Université de Perpignan (FR)
Université de Montpellier (FR)
Centre Hospitalier de Perpignan (FR)
Centre Hospitalier Universitaire de Montpellier (FR)
Centre Hospitalier de Béziers (FR)
Institut de Cancérologie de l'Ouest (FR)
Clinique Clémentville (FR)
Institut de Recherche en Cancérologie de Montpellier (FR)
Institut Sainte Catherine (FR)

Publication Details

Journal: The Oncologist
Published: 2026-01-13
DOI: https://doi.org/10.1093/oncolo/oyag006
Primary Topic: Colorectal Cancer Treatments and Studies
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

The BEVATOMOX phase II trial: raltitrexed/oxaliplatin/bevacizumab vs mFOLFOX6/bevacizumab in 2nd-line metastatic colorectal cancer

Thomas Simon, Stéphane Jacquot, Catherine Fiess, F. Khemissa Akouz et al.

Jan 13, 2026

The Oncologist

Colorectal Cancer Treatments and Studies

article

The BEVATOMOX phase II trial: raltitrexed/oxaliplatin/bevacizumab vs mFOLFOX6/bevacizumab in 2nd-line metastatic colorectal cancer

Thomas Simon, Stéphane Jacquot, Catherine Fiess, F. Khemissa Akouz, T. Mazard, Stephen G. Ellis, E. Samalin, E. Assenat, Marc Ychou, Mohamed Ramdani, Fabienne Portales, Laurent Mineur

January 13, 2026article en

Abstract

No abstract available for this paper.

The OncologistVol. 31(3)

Université de Perpignan (FR), Université de Montpellier (FR), Centre Hospitalier de Perpignan (FR), Centre Hospitalier Universitaire de Montpellier (FR), Centre Hospitalier de Béziers (FR), Institut de Cancérologie de l'Ouest (FR), Clinique Clémentville (FR), Institut de Recherche en Cancérologie de Montpellier (FR), Institut Sainte Catherine (FR)

Good health and well-being

Openalex Percentile: Top 87%

Colorectal Cancer Treatments and Studies

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.